Mathematical analysis and simulations involving chemotherapy and surgery on large human tumours under a suitable cell-kill functional response

Mathematical Biosciences and Engineering

Volumn 10, Issue 1, 2013, Pages 221-234

  Rodrigues, Diego Samuel ^a   De Arruda Mancera, Paulo Fernando ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chemotherapy; Mathematical modelling; Norton Simon hypothesis; Tumour

Indexed keywords

ANTINEOPLASTIC AGENT;

ALGORITHM; BIOLOGICAL MODEL; CONFERENCE PAPER; DRUG THERAPY; HUMAN; KINETICS; METHODOLOGY; NEOPLASM; ONCOLOGY; PATHOLOGY; STATISTICAL MODEL;

ALGORITHMS; ANTINEOPLASTIC AGENTS; DRUG THERAPY; HUMANS; KINETICS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASMS;

EID: 84874695009     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2013.10.221     Document Type: Conference Paper

References (33)

1. R. E. Bellman. "Mathematical Methods in Medicine," World Scientific Publishing Co. Inc., River Edge, 1983.
2. T. Browder, C. E. Butterfield, B. M. Kraling, B. Shi, B. Marshall, M. S. O'Reilly and J. Folkman, Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer, Cancer Res., 60 (2000), 1878-1886.
3. R. N. Buick, Cellular basis of chemotherapy, in "Cancer Chemotherapy Handbook" (Ed. R. T. Dorr and D. D. V. Hoff), Appleton & Lange, (1994), p.9.
4. L. G. de Pillis and A. E. Radunskaya, A mathematical tumor model model with immune resistance and drug therapy: An optimal control approach, J. Theor. Med., 3 (2001), 79-100.
5. L. G. de Pillis, W. Gu, K. R. Fister, T. Head, K. Maples, A. Murugan, T. Neal and K. Yoshida, Chemotherapy for tumors: Analysis of the dynamics and a study of quadratic and linear optimal controls, Math. Biosc., 209 (2007), 292-315.
6. A. D'Onofrio, U. Ledzewicz, H. Maurer and H. Schättler, An optimal delivery of combination therapy for tumors, Math. Biosc., 222 (2009), 13-26.
7. R. T. Dorr and D. D. Von Hoff, "Cancer Chemotherapy Handbook," McGraw-Hill, 1994.
8. FEC100 chemotherapy for breast cancer (Written by Jeremy Braybrooke). Document number: ASWCS09 BR006 [internet] accessed 27/07/2011 available from http://www.avon.nhs.uk/aswcs-chemo/STCP/index.htm.
9. N. Ferrara and H. P. Gerber, The role of vascular endothelial growth factor in angiogenesis, Acta Haematol., 106 (2001), 148-156.
10. K. R. Fister and J. C. Panetta, Optimal control applied to competing chemotherapeutic cell-kill strategies, SIAM J. Appl. Math., 63 (2003), 1954-1971.
11. R. A. Gatenby, Application of competition theory to tumour growth: Implications for tumour biology and treatment, Eur. J. Cancer, 32A (1996), 722-726.
12. R. S. Kerbel, Tumour angiogenesis: Past, present and the near future, Carcinogenesis, 21 (2000), 505-515.
13. M. Kohandel, S. Sivaloganathan and A. Oza, Mathematical modeling of ovarian cancer treatments: Sequencing of surgery and chemotherapy, J. Theor. Biol., 242 (2006), 62-68.
14. L. G. Marcu and E. Bezak, Neoadjuvant cisplatin for head and neck cancer: simulation of a novel schedule for improved therapeutic ratio, J. Theor. Biol., 297 (2012), 41-47.
15. R. B. Martin, M. E. Fisher, R. F. Minchin and K. L. Teo, Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells, Math. Biosc., 110 (1992), 221-252.
16. R. B. Martin and K. L. Teo, "Optimal Control of Drug Administration in Cancer Chemotherapy," World Scientific, 1994.
17. R. B. Martin, Optimal control drug scheduling of cancer chemotherapy, Automatica 28 (1992), 113-1123.
18. MeadJohnson Oncology Products [internet], http://patient. cancerconsultants.com/druginserts/Cyclophosphamide.pdf. accessed 29/02/2012.
19. R. D. Mosteller, Simplified calculation of body surface area, N. Engl. J. Med., (1987), 1098.
20. S. Mukherjee, "The Emperor of All Maladies: A Biography of Cancer," Scribner, 2010.
21. F. Nani and H. I. Freedman, A mathematical model of cancer treatment by immunotherapy, Math. Biosc., 163 (2000), 159-199.
22. L. Norton and R. Simon, The Norton-Simon hypothesis revisited, Cancer Treat. Rep., 70 (1986), 163-169.
23. S. T. R. Pinho, H. I. Freedman and F. K. Nani, A chemotherapy model for the treatment of cancer with metastasis, Math. Comp. Model., 36 (2002), 773-803.
24. S. T. R. Pinho, F. S. Bacelar, R. F. S. Andrade and H. I. Freedman, A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy, Nonlin. Anal.: Real World Appl., 14 (2013), 815-828.
25. D. S. Rodrigues, S. T. R. Pinho and P. F. A. Mancera, Um modelo matemático em quimioterapia, TEMA, 13 (2012), 1-12 (in portuguese).
26. D. S. Rodrigues, P. F. A. Mancera and S. T. R. Pinho, Accessing the effect of metronomic chemotherapy through a simple mathematical model, 2012, preprint.
27. F. M. Schaebel, Concepts for systematic treatment of micrometastases, Cancer, 35 (1975), 15-24.
28. H. E. Skipper, F. M. Schaebel-Jr. and W. S. Wilcox, Experimental evaluation of potential anticancer agents XIII: on the criteria and kinetics associated with curability of experimental leukemia, Cancer Chemother. Rep., 35 (1964), 1-111.
29. J. S. Spratt, J. S. Meyer and J. A. Spratt, Rates of growth of human neoplasms: part II, J. Surg. Oncol., 61 (1996), 68-73.
30. G. S. Stamatakos, E. A. Kolokotroni, D. D. Dionysiou, E. C. Georgiadi and C. Desmedt, An advanced discrete state-discrete event multiscale simulation model of the response of a solid tumour to chemotherapy: mimicking a clinical study, J. Theor. Biol., 266 (2010), 124-139.
31. V. G. Vaidya and F. J. Alexandro Jr., Evaluation of some mathematical models for tumor growth, Int. J. Biom. Comput., 13 (1982), 19-35.
32. World Health Organization, http://www.who.int/cancer/en/ accessed 02/03/2012.
33. R. A. Weinberg, "The Biology of Cancer," Garland Science, 2008.